OmniAb Investor Presentation Deck

Our Business LEVERAGING OUR PROPRIETARY DISCOVERY TECHNOLOGY PLATFORM WORLDWIDE Industry's Only 4-Species Platform Transgenic animals for fully human and bispecific antibody discovery O :: Leading and Proven Technology 70 partners have access to OmniAb antibodies 301 programs with 3 product approvals Sources: Clarivate Analytics Cortellis database. POISED FOR GROWTH TO MEET A GLOBAL INDUSTRY NEED One of the Largest Greenfields in the Pharma Industry $279 billion total addressable 11 market for antibodies by 2025 Innovation and Intelligent Expansion of Our Technology New technology launches in 2023 3 AI ML OmniAb

View entire presentation